Latest Articles
5 Articles
China has approved the NEO brain chip for mass production and patient use, marking a major milestone in brain-computer interface technology. The device helps paralyzed patients control digital devices with their thoughts and reaches commercialization ahead of Neuralink.
A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.
Bill Gates is visiting Rwanda to witness the country's impressive healthcare progress. The visit highlights Rwanda's success in community health, innovation, and partnerships that continue to improve lives while inspiring stronger healthcare systems across Africa.
by Joseph James Udoh
Bill Gates is visiting Rwanda to witness the country's impressive healthcare progress. The visit highlights Rwanda's success in community health, innovation, and partnerships that continue to improve lives while inspiring stronger healthcare systems across Africa.
by Joseph James Udoh
China has approved the NEO brain chip for mass production and patient use, marking a major milestone in brain-computer interface technology. The device helps paralyzed patients control digital devices with their thoughts and reaches commercialization ahead of Neuralink.
by Joseph James Udoh
A Harvard Medical School study found advanced AI systems outperformed doctors in emergency room diagnoses under controlled testing. Researchers say AI could become a powerful decision-support tool, improving diagnostic accuracy while complementing, not replacing human clinicians.
by Joseph James Udoh
Artificial intelligence is revolutionising genomics by speeding up genetic analysis, enabling precision medicine, improving drug discovery, and supporting large-scale health research. AI is helping deliver earlier diagnoses, more effective treatments, and better healthcare outcomes worldwide.
by Joseph James Udoh
Researchers at the University of Cambridge and DIOSynVax have developed an AI-powered vaccine platform designed to protect against entire virus families. Early trial results show strong safety and immune responses, raising hopes for broader disease prevention and pandemic preparedness.
by Joseph James Udoh